HILL STEPHEN J. (Chief Technical Ops. Officer) sold 0.6% of their position (109.00 shares) of LYELL IMMUNOPHARMA, INC. on the open market
Open‑market sale worth $2.5K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/11/2026ACC: 0001866154-26-000001
Officer· Chief Technical Ops. Officer
Since Jun 2021
+68.89K
Net shares
Net buyer
$2.5K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
69K acquired · 109.00 disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+4K
Price / share
—
Trade value
—
% of position
26.4%
2/9/2026
15.14K→19.14K
Common Stock
Direct
Shares
−109.00
Price / share
$23.12
Trade value
$2.52K
% of position
0.6%
2/10/2026
19.14K→19.03K
Total
Net shares
+3.89K
Net value
-$2.52K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/9/2026 | A · Award | +4K | — | — | 26.4% | 15.14K | 19.14K |
| Common Stock Direct | 2/10/2026 | S · Sale | −109.00 | $23.12 | $2.52K | 0.6% | 19.14K | 19.03K |
| Total | +3.89K | -$2.52K | ||||||
Derivative Transactions1
Option (right to buy)
Direct
Converts to
Common Stock
65K shares
Shares
+65K
Strike price
23.71
Held after
65K
Exercisable
—
2/10/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Option (right to buy) Direct | Common Stock65K shares | 2/10/2026 | A · Award | +65K | 23.71 | — | 65K |